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Lactic acid bacteria (LAB) are Gram positive nonpathogenic commensal organisms present in human gastrointestinal tract. In
vivo, LAB are separated from antigen-presenting cells such as dendritic cells (DC) by the intestinal epithelial barrier. In this study,
the impact of one LAB strain (Lactobacillus casei ATCC393) on human monocyte-derived DC from allergic and healthy donors
was assessed by using a polarized epithelium model. Confocal and ﬂow cytometer analyses showed that immature DC eﬃciently
captured FITC-labelled L. casei through the epithelial layer. After interaction with L. casei, DC acquired a partial maturation status
(i.e., CD86 and CD54 increase) and increased their interleukin (IL)-10 and IL-12 production. Interestingly, after activation by L.
casei in the presence of experimental epithelium, DC from allergic patients instructed autologous na¨ ıve CD4+ T cells to produce
more interferon-γ than without the epithelium. Thus by modulating human DC reactivity, LAB and intestinal epithelium might
modify T cell immune response and regulate the development of allergic reaction.
Copyright © 2007 C´ eline Ratajczak et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Dendritic cells (DC), known as professional antigen-presen-
ting cells, are involved in the regulation of mucosal immune
responses.Inperipheraltissues,contactwithantigeninduces
a maturation process and the migration of DC to secondary
lymphoid organs, where they induce the diﬀerentiation of
na¨ ıve T cells [1, 2]. The induced proﬁle (i.e., Th1, Th2, or
regulatory) depends on the nature of the signals received and
d eli v e r edb yDC[3].Inatopicpatients,DCplayapivotalrole
in the development and the maintenance of allergic diseases
characterized by a predominant Th2 proﬁle [3, 4].
The increased risk of allergic diseases observed in indus-
trialized countries was suggested to be related to western life
style characterized by a reduced overall exposure to micro-
bial stimulation in infancy [5–7]. Postnatal exposure to mi-
crobial antigens elicits preferentially Th1 or T regulatory re-
sponses, which have been suggested to counterbalance Th2-
polarized cytokine production in neonates. Insuﬃcient early
microbialexposuremayfavorthepersistenceofTh2-typecy-
tokinesproductionallowingthepotentialdevelopmentofal-
lergy. The intestine is one of the major immune organs of the
body where DC can encounter bacteria [8, 9]. The predom-
inant sites of antigen sampling are the Peyer patches, where
intestinal DC interact directly with luminal bacteria by pass-
ing their dendrites between epithelial tight junctions or after
transport of bacteria through M cells [10, 11].
Some commensal organisms are used as probiotics, that
is, live microbial food ingredients with health-promoting
properties [12]. Recent studies suggest that healthy gut mi-
crobiota may have a crucial role for the maturation of the
immune system to nonallergic mode. The intestinal ﬂora
of allergic children is less often colonized with lactobacilli
in comparison with nonallergic children [13]. A clinical
study demonstrates that perinatal administration of probi-
otic bacteria (Lactobacillus GG) halved the later development2 Journal of Biomedicine and Biotechnology
of atopic eczema in high-risk children [14, 15]. This eﬀect
may be due to the anti-inﬂammatory properties of probi-
otic bacteria. Consumption of Lactobacillus GG by children
with atopic dermatitis has been reported to enhance the gen-
eration of interleukin (IL)-10 in serum [16]. Moreover oral
feeding of mouse with heat-killed Lactobacillus casei (strain
shirota) inhibited speciﬁc IgE production [17]. As DC in-
habiting the gut, mucosa are constantly in close vicinity to
microorganisms, the intestinal ﬂora may exert regulatory ef-
fects through DC modulation. Lactobacilli were reported to
regulatemouseDCsurfacemoleculeexpressionandcytokine
production [18]. We previously demonstrated that three dif-
ferent LAB strains were able to inhibit the secretion of Th2
cytokines by peripheral blood mononuclear cells from aller-
gicdonors[19].Moreover,weconﬁrmedforoneofthestrain
(L. plantarum) the inhibition of the Th2 response induced
by Der p 1-pulsed DC from allergic patients in vitro. This
wasassociatedwithincreasedIL-12secretionbyDC,reduced
Th2 cytokine production (IL-4, IL-5), and increased produc-
tion of Th1 cytokine (interferon (IFN)-γ) by autologous T
cells [20].
The presence of LAB in the intestinal environment might
be an important factor required to avoid the development
of the allergy-associated Th2 response. In view of the crit-
ical importance of DC in the regulation of the immune
response, we analyzed the reactivity of human monocyte-
derived DC to the LAB L. casei (ATCC 393) by using a well-
deﬁned experimental model of intestinal epithelium. Thus
the eﬀect of a L. casei strain on activation patterns of DC
from allergic and healthy donors was investigated and the
impact on T cell-dependent cytokine production was eval-
uated.
2. MATERIALS AND METHODS
2.1. DCandTlymphocytespreparation
2.1.1. Donors
Blood was collected from allergic patients sensitive to
house dust mite (speciﬁc IgE antibodies; positive skin prick
tests towards Dermatophagoides pteronyssinus (Dpt) (RAST
class > 3); total serum IgE > 250kU/mL) and from healthy
donors(totalIgElevel<20kU/L;speciﬁcanti-Dptantibodies
<0.35kU/L).
2.1.2. Cellpreparation
Monocyte-derived DC were generated from blood mono-
cytes puriﬁed by positive selection using monoclonal anti-
CD14 antibodies coupled to magnetic microbeads (Miltenyi
Biotech, Bergsch Gladbach, Germany) as described [20].
Cells were cultured at 1 × 106 cells/ml for 5-6 days in com-
plete medium containing 25ng/ml granulocyte-macrophage
colony stimulating factor (GM-CSF) (Preprotech, London,
UK) and 10ng/ml IL-4 (R&D system, Oxon, UK) to obtain
immature DC. At the end of the culture, 95% of the popula-
tion is CD1a+HLA-DR+CD80/C86low.
Naive CD4+ T cells were isolated from the eluted CD14−
cell fraction by negative selection using a CD4+CD45RA+
T cell isolation kit (Miltenyi Biotech, Germany) (purity >
95%) and frozen until use.
2.2. Caco2-DCTranswellcoculturesystem
To mimic the intestinal barrier, we used an in vitro Tran-
swell coculture system as described [10]. Caco2 cell line was
grown in Dulbecco’s MEM (Cambrex Bio Sciences, Verviers,
Belgium) supplemented with 10% heat-inactivated fetal calf
serum(Invitrogen,Paisley,UK),1%nonessentialaminoacid
(Gibco BRL, UK), and antibiotics. Cells were seeded on
the upper face of 6.5mm ﬁlters (3μmp o r eT r a n s w e l lﬁ l -
ters, Corning Incorporated, Acton, MA) for 15 days un-
til a transepithelial resistance (TER) of ∼ 300Ω/cm2 was
achieved.Transwellﬁlterswereturnedupside-down,andim-
mature DC (1 × 106) were added for 3hr on the ﬁlter facing
the basolateral membrane of the epithelium to allow cell at-
tachment. Filters were replaced into 24-well plates. TER was
checked to be unchanged during the coculture with DC and
after L. casei stimulation (Grangette personal observation) as
described [21].
2.3. Preparationofbacteria
L. casei ATCC 393 was prepared as previously described [20].
Brieﬂy, the bacteria were cultured overnight in MRS broth
medium (Difco, Detroit, MI), at 37◦C. The bacterial suspen-
sion was diluted at 1 : 20 in fresh medium and further cul-
tured until exponential phase. After washing, bacteria were
resuspended in PBS containing 20% of glycerol and stored at
−80◦C before using. The bacteria concentration was deter-
mined as described [20].
As live and killed LAB were not diﬀerent in their capacity
to regulate peripheral blood mononuclear cells (PBMC) or
DC stimulation ([19, 20], Grangette personal observation),
we used killed LAB obtained after ﬁxation by 45min incu-
bation in endotoxin-free PBS 4% paraformaldehyde (PFA).
These killed LAB were stored at +4◦C until use.
2.4. Uptakeanalysis
2.4.1. FITC-labelledbacteria
Fixed bacteria were resuspended in RPMI (1ml) and incu-
bated with ethanol (2ml, 70%) for 1h at room tempera-
ture.Aftercentrifugation(2500g,15min),bacteriaweresus-
pended in carbonate/bicarbonate (pH = 9.7) buﬀer and in-
cubated with 0.1mg/ml ﬂuorescein isothiocyanate (FITC)
(Sigma,Germany)for1h,withconstantstirring.Afterwash-
ing in PBS 0.1% gelatine, bacteria were stored in RPMI at
−20◦C before use. FITC-labelled bacteria were added on the
apical side for 24 or 48h at the dose of DC/bacteria: 1/10,
1/100. TER were checked to be unchanged during this time.
2.4.2. Flowcytometeranalysis
Monocyte-derived DC from allergic (n=2) or healthy (n =
2) donors, adherent or not to the ﬁlter, were collected andC´ eline Ratajczak et al. 3
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Figure 1: Confocal analysis of FITC-labelled L. casei uptake by adherent DC. (a) Schematic view of the DC/epithelial cell culture model. The
dotted arrow indicates the section where the analysis was done. (b) The pictures represent diﬀerent sections of the same DC and show the
colocalization of FITC-bacteria into the cytoplasm of DC.
immediately analyzed by FACScalibur (Becton Dickinson,
San Diego, CA).
2.4.3. Cellstainingforconfocalmicroscopy
After 48h of culture, Transwell ﬁlters were washed and ﬁxed
30min in PFA (4%). After 15min treatment with PBS 0.5%
Triton (Hopkin & Williams) and 30min saturation with hu-
man serum (2% in PBS), ﬁlters were incubated either with
monoclonal anti-human CD11c antibody coupled to Phyco-
erythrin (PE) or with an irrelevant antibody (Becton Dick-
inson) for 30min. After washing, ﬁlters mounted with Flu-
oprep (Biom´ erieux SA, France) were analyzed with confocal
laser scanning microscope (SP2 AOBS, LCS software, Leica,
Wetzlar, Germany).
The dose of 100 bacteria for 1 DC, allowing the highest
uptakeintensityinpreliminarystudies,waschosenforallthe
experiments with the epithelium (data not shown).
2.5. DCactivation
After 48h of culture with bacteria, monocyte-derived DC
from allergic (n = 6) or from healthy (n = 7) donors were
harvested for phenotype analysis and their supernatants col-
lected. Only one test per individual was performed in each
group.
2.5.1. DCsurfacemarkeranalysis
Monocyte-derived DC adherent or nonadherent to the ﬁlter
were washed in PBS and incubated for 30min at 4◦Cw i t h
diﬀerent monoclonal antibodies (mAbs) : FITC-conjugated
anti-CD86, anti-HLA-DR, and PE-conjugated anti-CD80,
anti-CD54 or irrelevant mAbs (Becton Dickinson). Cells
were ﬁxed in PBS 1% PFA and analyzed using a FACScal-
ibur (Becton Dickinson). Variations in DC phenotype were
expressedasthediﬀerencebetweenmeanﬂuorescenceinten-
sity (MFI) minus the isotype control MFI (ΔMFI).
2.5.2. CytokineproductionbyDC
DC supernatants were harvested from the lower chamber of
the Transwell 48h following stimulation and assayed for the
presence of IL-10 or IL-12 (IL-12 p70) by speciﬁc ELISA (Di-
aclone, France). The sensitivity of both assays was 5pg/ml.
2.6. Tcellactivation
2.6.1. DC-Tcoculture
After 24hours of culture with bacteria, monocyte-derived
DC(allergic:n = 5;healthy:n = 5)activatedintheTranswell
system and adherent or not to the ﬁlter were harvested from
the lower chamber (Figure 1(a)). After washing, DC were re-
suspendedincompleteRPMImedium(105/ml)andcultured
with autologous CD4+CD45RA+ T cells (106/ml) (ratio: 1
DC/10 T lymphocytes) for 5 days. Only one test per indi-
vidual was performed in each group.
2.6.2. CytokineproductionbyTcells
Supernatants were collected and assayed for IL-5 (PharMin-
gen), IL-10, and IFN-γ (Diaclone) by speciﬁc ELISA (sensi-
tivity = 5pg/ml).4 Journal of Biomedicine and Biotechnology
2.7. Statisticalanalysis
Nonparametric statistical analyses were performed with
paired samples and the permutation tests (STATEXACT, Cy-
tel Software, MA). P values of .05 or less were considered sta-
tistically signiﬁcant.
3. RESULTS
3.1. DCareabletocaptureL.caseithrough
theintestinalepithelium
To evaluate the uptake of lactic acid bacteria (LAB) by DC
through a human intestinal epithelium, DC from healthy or
allergicdonorswereincubatedwithFITC-labelledL.caseifor
24 or 48hours in the Transwell coculture system. DC adher-
ent and nonadherent to the ﬁlter were harvested and ana-
lyzedseparately.ThenumberofDCadherenttotheﬁlterwas
slightly increased with DC from healthy donors compared to
allergic patients after L. casei stimulation (59800±28200 and
33900±2200 adherent cells per well, resp.), whereas unstim-
ulated DC from healthy and allergic donors similarly adhere
toepithelium(20417±4641and17000±5778,resp.).Bothin
allergic and healthy donors, the capture of FITC-bacteria by
DC directly adherent to the epithelium increased between 24
and 48h. In contrast, nonadherent DC captured fewer bac-
teria and only at 48h. For the analyzed donors, the uptake
of L. casei by DC was lower for allergic compared to healthy
donors (Figure 2). Higher percentages of FITC-positive cells
were detected when DC were directly incubated with bacte-
ria, without epithelium (data not shown).
The bacteria uptake through the intestinal epithelium
wasfurtherconﬁrmedbyconfocalmicroscopy.Diﬀerentsec-
tions of the same adherent DC detected with an anti-CD11c
antibody (Figure 1(a)) clearly showed a colocalization of
FITC-labelled L. casei into the DC cytoplasm (Figure 1(b)).
3.2. DCacquireamoderatematurationstatus
uponL.caseistimulationthrough
theintestinalepithelium
To determine whether maturation of DC by L. casei,i n
the presence of the epithelium, is associated with pheno-
typic changes; the expression of CD80, CD86, HLA-DR, and
CD54 (intercellular adhesion molecule (ICAM)-1) was as-
sessed. L. casei induced a low increase in the expression of
the costimulatory molecules CD86 (P<. 05 for adherent and
nonadherent DC from allergic patients) and CD54 (P<. 05
for adherent DC from allergic donors) on DC from healthy
and allergic donors, whether they were adherent or not to
the epithelium. The expression of MHC II (HLA-DR) and
CD80 was not modiﬁed by the stimulation with L. casei on
DC from both allergic and healthy donors (Figure 3). These
resultssuggestthatL.caseiinducesamoderatematurationof
DC in presence of the epithelium.
3.3. CytokineproductionbyL.casei-stimulatedDC
The production of IL-10 and IL-12, involved in the orienta-
tionoftheimmuneresponse,wasanalyzed.DCfromhealthy
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Figure 2: DC take up FITC-labelled L. casei through an intestinal ep-
ithelial layer. Monocytes from allergic patients and healthy donors
werediﬀerentiatedinDCinthepresenceofGM-CSFandIL-4for5-
6days.CellswerethenpulsedwithunlabelledorwithFITC-labelled
L.casei (ratio bacteria/DC: 100/1) for 24 or 48hours in the presence
of an intestinal epithelial layer. DC, adherent and nonadherent to
t h eﬁ l t e r ,w e r eh a r v e s t e da n da n a l y z e db yﬂ o wc y t o m e t r y .( a )T h e
percentage of FITC-positive cells is evaluated into the gate repre-
sented on the dot plots. (b) Open histograms represent the ﬂuo-
rescence of DC incubated with unlabelled L. casei, and closed his-
tograms represent the capture of FITC-labelled L. casei by DC. The
percentages of FITC-positive cells are indicated. One representative
experiment is shown for both donor types.
donors incubated with L. casei signiﬁcantly produced IL-10
and IL-12 48h after the stimulation, with similar levels in
the presence or in the absence of the intestinal epithelium
(Figure 4(a)). In contrast, DC from allergic patients incu-
bated with L. casei only slightly increased IL-10 and IL-12
production in the absence of the epithelium, whereas the se-
cretion of these two cytokines was ampliﬁed in the presence
of the epithelial layer (P<. 05) (Figure 4(b)), suggesting a
role of the epithelium in the L. casei-induced cytokine pro-
duction by DC from allergic donors.
3.4. CytokineproductionbynaiveCD4+ Tcells
To evaluate the eﬀect of L. casei on the orientation of the re-
sponse induced by DC from allergic and healthy donors, theC´ eline Ratajczak et al. 5
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Figure 3: Eﬀect of L. casei stimulation on DC phenotype. Monocyte-derived dendritic cells from house dust mite sensitive-patients (a) and
(b) and from healthy donors (c) and (d) were exposed (dark grey line) or not (grey line) to L. casei for 48hours in the Transwell model.
(a) and (c) Adherent DC were analyzed by ﬂow cytometry for CD80, CD86, HLA-DR, and CD54 expression. the black line represents the
reactivity of ﬂuorochrome-matched isotype control mAbs. One representative experiment (out of 6 and 7, for allergic and healthy donors,
resp.) is shown. (b), (d) The mean ﬂuorescence intensity (ΔMFI) of the expression of each marker by adherent and nonadherent DC after
stimulation with medium, and L.casei is represented for both allergic ((b), n = 6) and healthy donors ((d), n = 7). ∗P<. 05.
production of IFN-γ (Th1 cytokine), IL-5 (Th2 cytokine),
and IL-10 (cytokine produced by some regulatory T cells) by
autologous naive T cells was analyzed. As no diﬀerences were
detectedinthematurationstatusbetweenadherentandnon-
adherent DC and as L. casei capture was more eﬃcient in ad-
herent DC, adherent DC were chosen for T cell stimulation.
Without epithelium, L. casei mainly increased the IFN-
γ production by naive T cells instructed by DC from healthy
donors(62.40±34.88comparedto39.45±26.13formedium
condition). IL-5 and IL-10 production by T cells was less
increased. No increase in these cytokine levels was detected
with L. casei-activated DC from allergic donors. In healthy
donors, the sole presence of Caco2 epithelial layer (with-
out L. casei stimulation) decreased the IFN-γ production by
DC-instructed T cells (5.35 ± 5.58ng/ml with the epithe-
lium compared to 39.45 ± 26.13ng/ml without the epithe-
lium). In contrast, for all cytokine production, the increase
induced by L. casei-stimulated DC from healthy or allergic
donors was further enhanced if DC were conditioned by the
epithelium. The increase in cytokine production for T cells
activated by L. casei- s t i m u l a t e dD Cw a sm o r ep r o n o u n c e d
for IFN-γ (26.75±8.02ng/ml for the L. casei condition com-
pared to 9.72 ± 10.41ng/ml for the medium condition for
allergic patients; 48.60 ± 16.68ng/ml for the L. casei condi-
tion compared to 5.35 ±5.58ng/ml for healthy donors). The
increase in cytokine production for allergic donors reached
similar levels to healthy donors for IL-5 and IL-10, whereas
IFN-γ levels remained higher for healthy donors (Figure 5).
4. DISCUSSION
The mucosal immune system is continuously exposed to di-
etary and microbial antigens and needs to react with appro-
priate immune responses. Compelling evidence suggested
that appropriate microbial colonization of the gut is impor-
tant in providing signals to prevent the overexpression of
Th2-dominated atopic responses [22]. In the last few years,
the potential role of selected probiotic strains in the preven-
tion of allergic diseases has become more evident. Neverthe-
less the mechanism underlying these properties remains un-
known. Intestinal epithelial cells permanently interact with
the luminal content, including the commensal ﬂora, and the6 Journal of Biomedicine and Biotechnology
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Figure 4: L. casei-stimulated DC produce IL-12 and IL-10. Monocytes-derived DC from healthy (a) and allergic (b) donors were pulsed or
not for 48hours with L. casei through an intestinal epithelial layer or not. Supernatants were collected and the amounts of IL-10 and IL-12
were measured by speciﬁc ELISA. Results are expressed as mean ± SEM (n = 5 for allergic donors and n = 5 healthy donors). ∗P<. 05.
cellular network of immune cells. Because of their location
at mucosal sites and their implication in the initiation of the
immune reaction, DC play a key role in this process. In order
to evaluate the involvement of DC intestinal environment on
their function, we used a well-established model of epithelial
c e l l sa n dD Cc o c u l t u r e[ 10, 21, 23]. We analyzed the eﬀect of
a selected L. casei strain, which was previously demonstrated
to reduce allergen-speciﬁc Th2 secretion in vitro [20]. In the
present study, we demonstrated that monocyte-derived DC
from healthy or allergic donors take up nonpathogenic L.
casei through an intestinal epithelium. The analysis of the
FITC-bacteriauptakeintheTranswellmodelshowedthatthe
process is time-dependent, increasing between 24 and 48h,
and higher in healthy donors compared to allergic ones. The
number of DC which have captured bacteria through the ep-
ithelium was low even after 48h in comparison with DC di-
rectly interacting with L. casei (without the epithelium). Us-
ingﬂuorescentbeads,wecheckedthatbeadsincubatedinthe
upper chamber did not pass through the epithelium. More-
over, because no change in TER was observed, we hypothe-
size that in our conditions DC open tight junctions and sam-
ple bacteria by extending their dendrites through the epithe-
lium without disrupting epithelial integrity as it was previ-
ously demonstrated in the same model [10]. This active pro-
cess may explain the time required to capture bacteria eﬃ-
ciently in the presence of the epithelium. By confocal analy-
sis,weclearlyconﬁrmedthebacteriauptakebyDCasL.casei
colocalized with adherent DC.
Byproducingcytokinesand/orbyexpressingspeciﬁccos-
timulatory molecules, DC can modulate the development
of T cell response and are considered as pivotal cells in the
development or the limitation of the allergic reaction. DC
phenotype and functions are dependent upon their mucosal
environment. In particular, intestinal epithelial cells condi-
tion DC to become “noninﬂammatory” in vitro and may
be involved in their capacity to maintain gut homeostasis
[21, 24]. Here we showed that DC from both allergic and
healthy donors acquired an intermediate maturation status
characterized by a moderate expression of cell-surface cos-
timulatory molecules and maturation markers upon stim-
ulation with L. casei in the presence of the intestinal ep-
ithelium. This intermediate maturation status has previously
been described in diﬀerent experimental settings. The abil-
ity of two Gram-positive bacteria, pathogenic Streptococcus
pyogenes, and nonpathogenic Lactobacillus rhamnosus to in-
duce monocyte-derived DC maturation has been compared.
S. pyogenes was shown to be a more potent stimulator of
DC maturation than L. rhamnosus. Indeed, this lactic acid
bacteria induced a partial DC maturation, as evidenced by
the moderate expression of costimulatory molecules CD80,
CD83, and CD86 and a weak cytokine and chemokine re-
sponse [25]. The same observations were reported with ac-
tivation by direct contact of human DC by a Gram-negative
pathogenic bacteria compared to L. rhamnosus and with ac-
tivation of murine DC with various strains of Lactobacilli
[18,26].Similarly,inamodelofintestinalepithelium,activa-
tion with L. plantarum induced a lower expression of CD80
and CD83 compared with activation with Gram-negative
pathogenic bacteria [24]. As costimulatory molecules are in-
volvedincontactbetweenDCandTcellsduringantigenpre-
sentation, a moderate expression of these molecules may re-
sult in orientation toward a T regulatory pathway [27].
The cytokine microenvironment plays a critical role dur-
ing T cell polarization. For example, IL-12 is important
to skew T cell diﬀerentiation towards Th1-type response,
and IL-10 is associated with immunoregulatory processes
[28, 29]. Here we showed that L. casei-induced IL-10, and
IL-12 production by DC from allergic donors was lower
compared to healthy donors, which may be related to a lower
adherence to the epithelium and a lower number of DC
which have captured L. casei.H o w e v e r ,a st h i sl o w e rp r o -
duction of IL-10 and IL-12 by DC from allergic donors was
also obtained after L. casei stimulation in the absence of the
epithelium, this suggests a dysfunction of DC from allergic
compared to healthy donors. Both cytokines were shown to
be produced by murine DC stimulated by a mixture of bi-
ﬁdobacteria and lactobacilli (VSL#3) [30]. We also noticed
that, in the presence of the intestinal epithelium, DC fromC´ eline Ratajczak et al. 7
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Figure 5: Production of cytokine by na¨ ıve CD4+ Tc e l l s . Monocyte-derived DC from allergic patients and healthy donors were incubated with
L. casei or medium only for 24hours, either directly in contact with cells (without epithelium) or through an intestinal epithelial layer (with
epithelium). Adherent DC were harvested from the lower chamber of the Transwell, cultured with na¨ ıve autologous CD4+ T cells for 5 days.
Supernatants were collected and the amounts of IFN-γ, IL-10, and IL-5 were measured by speciﬁc ELISA. Results are expressed as mean ±
SEM of cytokine percentage increase above L. casei stimulation (n = 5 for both allergic and healthy donors).
allergic patients produced higher levels of IL-12 and IL-10
compared to cells directly in contact with bacteria. The in-
teractions of L. casei with epithelial cells might have an eﬀect
on IL-12 and IL-10 secretion by DC from allergic patients,
therefore balancing the potential defect in their production.
Indeed, some mediators released by epithelial cells might in-
duce “noninﬂammatory DC,” which contribute to maintain
gut immune homeostasis, and limit excessive inﬂammatory
reactions like allergy [31]. Consequently, in allergic patients,
stimulation with nonpathogenic L. casei associated with the
anti-inﬂammatory eﬀect of the epithelium might favor the
development of semimature DC, characterized by moderate
expression of costimulatory moleculesand low cytokine pro-
duction that could counterbalance the Th2-biased immune
response [27, 32].
T cell activation and polarization of the immune re-
sponse may be inﬂuenced by DC maturation status and DC
cytokineproductioninducedbyL.casei.Inthepresentstudy,
we showed that the epithelium increased the cytokine pro-
duction by autologous T cells instructed by Lc a s e i -activated
DC derived from healthy and allergic donors, and espe-
cially the IFN-γ.I n c r e a s e dI F N - γ induced by LAB has pre-
viously been shown in a system of direct contact with bac-
teria using DC from allergic and healthy donors [20, 33].
In vivo, another LAB strain (L. plantarum) exhibited Th1
promoting capacity in a murine model of birch pollen al-
lergy [34]. IL-5 and IL-10 production were measured to an-
alyze the eﬀect of LAB activation on the Th2 or on the im-
munoregulatory responses, respectively. L. casei-pulsed ad-
herent DC conditioned by the intestinal epithelium moder-
ately increased the secretion of IL-5 and IL-10 in both aller-
gic and healthy donors. The increase in IL-5 production is
in agreement with a previous study using DC derived from
healthy donors and activated by L. plantarum in the presence
of an intestinal epithelial monolayer [24]. However, in the
absence of the epithelium, L. plantarum has been shown to
reducetheTh2response inducedbyDCfromallergicdonors
stimulated by the relevant allergen; whilst it did not modify
the response in healthy donors [20]. This suggests that LAB
may diﬀerentially regulate the immune response according
to their environment. Selective lactobacilli strains (L. casei
and L. reuteri) have been demonstrated to drive the gener-
ation of regulatory IL-10+ T cells through DC activation in
vitro [35]. Moreover, L. rhamnosus has been shown to in-
duce a peripheral hyporesponsiveness in stimulated CD4+ T
cells [36]. IL-10 is a cytokine known to limit an inﬂamma-
tion due to IFN-γ or IL-5 production. Even though, in our
experiment, the moderate increased secretion of IL-10 in the
coculture of T cells with L. casei-pulsed adherent DC may
be due to increased production by DC, the balance between8 Journal of Biomedicine and Biotechnology
IL-10 and IFN-γ or IL-5 might regulate potential immune
regulatory pathways. Thus, strains of lactobacilli might dif-
ferentially aﬀect DC and lead to the development of diﬀerent
T cell responses but each mechanism seems to control the
immune homeostasis. Moreover, although DC nonadherent
to the ﬁlter, that is, not in direct contact with the epithelium,
exhibited a similar maturation status compared to adherent
DC, nonadherent DC from both allergic and healthy donors
failed to increase T cell cytokine production upon L. casei
stimulation (data not shown). These results indicate that the
epithelium plays a role in the capacity of L. casei-activated
DC to regulate T cells, even though the sole presence of the
epithelium decreases the Th1 response as previously demon-
strated [31]. DC in contact with L. plantarum and epithe-
lial cells in the Transwell model have been shown to be more
“inﬂammatory”becauseoftheircapacitytoreleaseIL-12,IL-
10 and to promote T cell proliferation, compared to DC ac-
tivated only by epithelial mediators [24]. The crosstalk be-
tween epithelial cells, DC, and LAB might allow on the one
handtheestablishmentofaprotectiveeﬀectagainstanyanti-
gen encountered, vital for combating pathogenic organisms,
and on the other hand the limitation of potentially damag-
inginﬂammatoryimmunereactionsagainstendogenousmi-
croﬂora.
In conclusion, our results demonstrate eﬃcient interac-
tions between L. casei and DC through the intestinal epithe-
lium. By modulating DC function and by preserving its ca-
pacity to react against harmful pathogenic organisms, L. ca-
sei may contribute to maintain the homeostasis of the gut
immune system. Finally, by limiting inappropriate immune
activation, L. casei might prevent or reduce inﬂammatory re-
sponses such as the development of an allergic inﬂammatory
response.
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